- Home
- CVLT vs ACLX Comparison
CVLT vs ACLX Comparison
Compare CVLT & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVLT
- ACLX
- Stock Information
- Founded
- CVLT 1996
- ACLX 2015
- Country
- CVLT United States
- ACLX United States
- Employees
- CVLT N/A
- ACLX N/A
- Industry
- CVLT Computer Software: Prepackaged Software
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- CVLT Technology
- ACLX Health Care
- Exchange
- CVLT Nasdaq
- ACLX Nasdaq
- Market Cap
- CVLT 8.1B
- ACLX 3.5B
- IPO Year
- CVLT 2006
- ACLX 2022
- Fundamental
- Price
- CVLT $165.05
- ACLX $69.02
- Analyst Decision
- CVLT Buy
- ACLX Strong Buy
- Analyst Count
- CVLT 10
- ACLX 14
- Target Price
- CVLT $182.75
- ACLX $111.42
- AVG Volume (30 Days)
- CVLT 506.4K
- ACLX 526.8K
- Earning Date
- CVLT 07-29-2025
- ACLX 08-07-2025
- Dividend Yield
- CVLT N/A
- ACLX N/A
- EPS Growth
- CVLT N/A
- ACLX N/A
- EPS
- CVLT 1.68
- ACLX N/A
- Revenue
- CVLT $995,619,000.00
- ACLX $76,809,000.00
- Revenue This Year
- CVLT $15.91
- ACLX N/A
- Revenue Next Year
- CVLT $11.79
- ACLX $112.68
- P/E Ratio
- CVLT $98.24
- ACLX N/A
- Revenue Growth
- CVLT 18.63
- ACLX N/A
- 52 Week Low
- CVLT $119.67
- ACLX $47.86
- 52 Week High
- CVLT $192.01
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- CVLT 36.79
- ACLX 62.53
- Support Level
- CVLT $161.34
- ACLX $67.46
- Resistance Level
- CVLT $176.41
- ACLX $69.63
- Average True Range (ATR)
- CVLT 5.28
- ACLX 2.10
- MACD
- CVLT -0.94
- ACLX 0.36
- Stochastic Oscillator
- CVLT 22.10
- ACLX 90.76
About CVLT Commvault Systems Inc.
CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Cleanroom Recovery, HyperScale X, Air Gap Protect, Compliance, Cloud Rewind, and Clumio Backtrack. The company operates in the United States and exports to many other countries.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.